Oncolytics Biotech Enters Purchase Agreement
Ticker: ONCY · Form: 6-K · Filed: Apr 10, 2025 · CIK: 1129928
Sentiment: neutral
Topics: agreement, financing
TL;DR
Oncolytics Biotech inked a deal with Alumni Capital LP on April 10, 2025.
AI Summary
On April 10, 2025, Oncolytics Biotech Inc. entered into a purchase agreement with Alumni Capital LP. This filing incorporates the purchase agreement as Exhibit 99.1, which is also referenced in Oncolytics' Form F-10 registration statement.
Why It Matters
This agreement could signify a new financing or partnership for Oncolytics Biotech, potentially impacting its future development and operations.
Risk Assessment
Risk Level: low — The filing is a routine report of a contractual agreement and does not contain significant new financial or operational information that would immediately alter risk.
Key Players & Entities
- Oncolytics Biotech Inc. (company) — Registrant
- Alumni Capital LP (company) — Counterparty to purchase agreement
- April 10, 2025 (date) — Date of purchase agreement
FAQ
What is the nature of the purchase agreement between Oncolytics Biotech Inc. and Alumni Capital LP?
The filing does not specify the exact terms or purpose of the purchase agreement, only that it was entered into on April 10, 2025.
What is Exhibit 99.1 referenced in the filing?
Exhibit 99.1 is the Purchase Agreement dated April 10, 2025, between Oncolytics Biotech Inc. and Alumni Capital LP.
How does this filing relate to Oncolytics Biotech's Form F-10 registration statement?
Exhibit 99.1, the purchase agreement, is incorporated by reference into Oncolytics Biotech Inc.'s Registration Statement on Form F-10 (File No. 333-281009).
What is the primary purpose of this Form 6-K filing?
This Form 6-K is filed to report the execution of a purchase agreement by Oncolytics Biotech Inc. and to furnish the agreement as an exhibit.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada, with its principal executive offices located at Suite 804, 322 11th Avenue SW, Calgary, Alberta, Canada T2R 0C5.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 10, 2025 regarding ONCOLYTICS BIOTECH INC (ONCY).